Kaos Capital Ltd - 25 Nov 2025 SCHEDULE 13D Report for PSYENCE BIOMEDICAL LTD. Common Stock, without par value (PBM)

Filing Manager
Kaos Capital Ltd
Reporting Manager
KAOS Capital Ltd.
Security
PSYENCE BIOMEDICAL LTD. Common Stock, without par value
Symbol
PBM
Shares outstanding
1.87M shares
Disclosed Ownership
314K shares
Ownership
16.8%
Form type
SCHEDULE 13D
Filing time
10 Dec 2025, 18:09:10 UTC
Date of event
25 Nov 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
KAOS Capital Ltd. 16.77% 314K 0 314K /s/ Adam Arviv Adam Arviv / Chief Executive Officer 0002100448
Adam Arviv 16.77% 314K 0 314K /s/ Adam Arviv Adam Arviv, Individually 0002100451